Literature DB >> 25728273

MicroRNA-575 targets BLID to promote growth and invasion of non-small cell lung cancer cells.

Hongwei Wang1, Chunhua Yan1, Xiaodong Shi2, Jiaolin Zheng2, Lili Deng3, Lei Yang4, Fangfei Yu1, Yuandi Yang1, Yuxia Shao5.   

Abstract

This study was designed to detect miR-575 expression and function in non-small cell lung cancer (NSCLC). A higher expression of miR-575 in NSCLC tissues was observed compared with adjacent non-neoplastic tissues. Furthermore, re-introduction of miR-575 significantly promoted cell proliferation, migration, and invasion in the NSCLC line. Moreover, we showed that BLID is negatively regulated by miR-575 at the posttranscriptional level, via a specific target site within the 3'UTR. Overexpression of BLID counteracted miR-575-induced proliferation and invasion in NSCLC cells. The expression of BLID is frequently downregulated in NSCLC tumors and cell lines and inversely correlates with miR-575 expression. The findings of this study contribute to the current understanding of the functions of miR-575 in NSCLC.
Copyright © 2015 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Entities:  

Keywords:  BLID; MicroRNA-575; Non-small cell lung cancer; Oncogene

Mesh:

Substances:

Year:  2015        PMID: 25728273     DOI: 10.1016/j.febslet.2015.02.013

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   3.864


  22 in total

1.  Retraction: MicroRNA-410 Suppresses Migration and Invasion by Targeting MDM2 in Gastric Cancer.

Authors: 
Journal:  PLoS One       Date:  2022-06-08       Impact factor: 3.752

2.  Retraction: MicroRNA-137 Upregulation Increases Bladder Cancer Cell Proliferation and Invasion by Targeting PAQR3.

Authors: 
Journal:  PLoS One       Date:  2022-06-08       Impact factor: 3.752

3.  MicroRNA-124 upregulation inhibits proliferation and invasion of osteosarcoma cells by targeting sphingosine kinase 1.

Authors:  Yan Zhou; Yanzhen Han; Zhitao Zhang; Zhe Shi; Liyuan Zhou; Xiaohong Liu; Xiaoyan Jia
Journal:  Hum Cell       Date:  2016-10-14       Impact factor: 4.374

4.  DRP1 contributes to head and neck cancer progression and induces glycolysis through modulated FOXM1/MMP12 axis.

Authors:  Tai-Lin Huang; Chuang-Rung Chang; Chih-Yen Chien; Gong-Kai Huang; Yi-Fan Chen; Li-Jen Su; Hsin-Ting Tsai; Yu-Sheng Lin; Fu-Min Fang; Chang-Han Chen
Journal:  Mol Oncol       Date:  2022-04-15       Impact factor: 7.449

5.  Expression of Chemokine XCL2 and CX3CL1 in Lung Cancer.

Authors:  Bing Zhou; Heyun Xu; Kewei Ni; Xuming Ni; Jian Shen
Journal:  Med Sci Monit       Date:  2016-05-09

6.  Identification of biomarker microRNAs for predicting the response of colorectal cancer to neoadjuvant chemoradiotherapy based on microRNA regulatory network.

Authors:  Yaqun Zhu; Qiliang Peng; Yuxin Lin; Li Zou; Peipei Shen; Feifei Chen; Ming Min; Li Shen; Jiajia Chen; Bairong Shen
Journal:  Oncotarget       Date:  2017-01-10

7.  Valproic acid improves second-line regimen of small cell lung carcinoma in preclinical models.

Authors:  Roland Hubaux; Fabian Vandermeers; Jean-Philippe Cosse; Cecilia Crisanti; Veena Kapoor; Steven M Albelda; Céline Mascaux; Philippe Delvenne; Pascale Hubert; Luc Willems
Journal:  ERJ Open Res       Date:  2015-10-19

8.  Long noncoding RNA MIR31HG inhibits hepatocellular carcinoma proliferation and metastasis by sponging microRNA-575 to modulate ST7L expression.

Authors:  Shaoying Yan; Zhenrong Tang; Ke Chen; Yuyang Liu; Gangfeng Yu; Qiuxu Chen; Hao Dang; Fengjiao Chen; Jiaji Ling; Liying Zhu; Ailong Huang; Hua Tang
Journal:  J Exp Clin Cancer Res       Date:  2018-09-03

9.  Altered Expression of miR-575 in Glioma is Related to Tumor Cell Proliferation, Migration, and Invasion.

Authors:  Guangxin Wei; Shengjun Li; Pengcheng Wang; Shouxian Wang; Yujing Zhao
Journal:  Neuromolecular Med       Date:  2021-07-16       Impact factor: 3.843

10.  Long Non-Coding RNA GAPLINC Promotes Tumor-Like Biologic Behaviors of Fibroblast-Like Synoviocytes as MicroRNA Sponging in Rheumatoid Arthritis Patients.

Authors:  Bi Yao Mo; Xing Hua Guo; Meng Ru Yang; Fang Liu; Xuan Bi; Yan Liu; Lin Kai Fang; Xi Qing Luo; Julie Wang; Joseph A Bellanti; Yun Feng Pan; Song Guo Zheng
Journal:  Front Immunol       Date:  2018-04-10       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.